Login
$AXGN
$55.38 -$0.55 (0.98%) Live

$AXGN SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 8-K: Regulation FD Disclosure

Prostate Nerve Reconstruction Investor Event November 9, 2026

28 Oct 2026 FORM 10-Q
28 Oct 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

ALACHUA and TAMPA, FL – October 28, 2026 – Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and busi...

02 Oct 2026 SCHEDULE 13G
01 Oct 2026 8-K: Regulation FD Disclosure

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

10 Sep 2026 424B5
10 Sep 2026 8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure

This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of September 9, 2026, is entered into by and among Axogen, Inc., a Minnesota corporation (“Buyer”), Omega Merger Sub, Inc., a Georgia corporation and a wholly-owned subsidiar...

10 Sep 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more

Axogen, Inc., a Minnesota corporation (the “Company”) confirms its agreement with BofA Securities, Inc. (“BofA Securities”), Jefferies LLC (“Jefferies”), Wells Fargo Securities, LLC (“Wells Fargo”) and each of the other Underwriters name...

04 Sep 2026 Form 4: Tyndall Joseph A., Director

Sold 3,500 shares ($174K)

02 Sep 2026 144
14 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 Form 4: Began Marc A, EVP & General Counsel

Received 67,500 shares by exercise or conversion ($551K) · Sold 67,500 shares ($3.2M)

12 Aug 2026 Form 4: Wendell Amy McBride, Director

Received 13,353 shares by exercise or conversion ($198K) · Sold 13,353 shares ($647K)

11 Aug 2026 Form 4: Weiler Kathy Johnson, Director

Sold 14,150 shares ($641K)

11 Aug 2026 144
10 Aug 2026 144
07 Aug 2026 144
31 Jul 2026 SCHEDULE 13G/A
29 Jul 2026 FORM 10-Q

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support